Research Topics
| R JulianoSummaryAffiliation: University of North Carolina Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesR L Juliano
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
J Drug Target 21:27-43. 2013..Hopefully, the basic information presented in this review will be of value to investigators involved in designing delivery approaches for oligonucleotides...
The chemistry and biology of oligonucleotide conjugatesR L Juliano
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, 27599, United States
Acc Chem Res 45:1067-76. 2012..Although both of these strategies have had some success, further research is needed before oligonucleotide conjugates can find an important place in human therapeutics...
Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotidesRudolph L Juliano
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA
Bioconjug Chem 23:147-57. 2012..In this review, we examine the recent literature on oligonucleotide internalization and subcellular trafficking in the context of current insights into the basic machinery for endocytosis and intracellular vesicular traffic...
Epigenetic manipulation of gene expression: a toolkit for cell biologistsRudy L Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA
J Cell Biol 169:847-57. 2005..However, we will restrict our comments primarily to the cell culture situation, only briefly alluding to fundamental differences between utilization in animals versus cells...
Intracellular delivery of oligonucleotide conjugates and dendrimer complexesR L Juliano
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
Ann N Y Acad Sci 1082:18-26. 2006....
Challenges to macromolecular drug deliveryR Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill NC 27599, USA
Biochem Soc Trans 35:41-3. 2007....
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesRudy Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA
Nucleic Acids Res 36:4158-71. 2008..Thus, choice of an optimal delivery modality will likely depend on the therapeutic context...
Biological barriers to therapy with antisense and siRNA oligonucleotidesR Juliano
UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA
Mol Pharm 6:686-95. 2009..An understanding of the biological processes underlying these barriers will aid in the design of more effective delivery systems...
Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agentsRudolph L Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill, USA
Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:324-35. 2009..The article also briefly discusses several specific examples of the use of CTPs or CPPs to assist in the delivery of nanoparticles, liposomes, and other nanocarriers...
The Carolina Center of Cancer Nanotechnology Excellence: past accomplishments and future perspectivesRudy L Juliano
University of North Carolina, Chapel Hill, NC 27599, USA
Nanomedicine (Lond) 6:19-24. 2011....
Peptide-oligonucleotide conjugates for the delivery of antisense and siRNARudolph L Juliano
University of North Carolina, Department of Pharmacology, School of Medicine, Chapel Hill, NC 27599, USA
Curr Opin Mol Ther 7:132-6. 2005..This article will provide a perspective on issues in oligonucleotide delivery, and will examine recent literature on the preparation and use of several types of peptide-oligonucleotide conjugates...
Integrins and GTPases in tumour cell growth, motility and invasionP Keely
Dept of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill 27599, USA
Trends Cell Biol 8:101-6. 1998..In this review, the authors examine integrin signalling and integrin-GTPase interplay in the context of cancer cell growth and behaviour...
Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotidesR L Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill 27599, USA
Pharm Res 16:494-502. 1999..The problems and advantages inherent in the use of delivery systems are discussed in the light of further enhancing in vivo pharmacological actions of oligonucleotides...
Aspects of the transport and delivery of antisense oligonucleotidesR L Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA
Curr Opin Mol Ther 2:297-303. 2000..It will also examine the merits of various delivery strategies for oligonucleotides. The use of conjugates of oligonucleotides with 'cell penetrating peptides' as a promising delivery technology will be emphasized...
Critical issues in PhD training for biomedical scientistsR L Juliano
Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599 7365, USA
Acad Med 76:1005-12. 2001..They conclude that it is in the interest of faculty and institutions to make these and other drastic changes because the current system is both inherently unfair and self-destructive...
Integrin regulation of cell signalling and motilityR L Juliano
Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA
Biochem Soc Trans 32:443-6. 2004..These studies emphasize the intricate connection between integrins and Rho-family GTPases and their effectors in controlling both mitogenesis and migration...
Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome eraR L Juliano
Department of Pharmacology, School of Medicine and Program in Macromolecular Therapeutics, University of North Carolina, Chapel Hill 27599, USA
Mol Interv 1:40-53. 2001..Thus, the therapeutic use of macromolecules, including oligonucleotides, peptides, and proteins, may be an idea whose time has come...
Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily membersR L Juliano
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
Annu Rev Pharmacol Toxicol 42:283-323. 2002..These mechanisms often involve the ability of cell adhesion molecules to initiate the formation of organized structures or scaffolds that permit the efficient flow of information in signaling pathways...
The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotidesLeaf Huang
Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
J Drug Target 18:567-74. 2010..We also reprise several recent studies that have examined the inter-relationship of size and shape in influencing delivery...
Movin' on through with Cdc2Rudy Juliano
Nat Cell Biol 5:589-90. 2003
Bugging tumors to put drugs on targetRudy Juliano
Department of Pharmacology and the Carolina Center of Cancer Nanotechnology Excellence, School of Medicine, University of North Carolina, Chapel Hill, USA
N Engl J Med 356:954-5. 2007
Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathwaysJung Weon Lee
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
Mol Cells 17:188-202. 2004..2003)...
Increased uptake of antisense oligonucleotides by delivery as double stranded complexesAnna Astriab-Fisher
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
Biochem Pharmacol 68:403-7. 2004..The results obtained suggested that double stranded delivery could provide a simple and effective means for enhancing cell uptake of pharmacologically active oligonucleotides...
In honour of Professor Rudy Juliano, winner of the 2004 Life-time Achievement Award from the Journal of Drug TargetingSaghir Akhtar
J Drug Target 12:309-11. 2004
A Festschrift in honour of Professor Rudy Juliano, winner of the 2004 Life-time Achievement Award from the Journal of Drug TargetingRudy Juliano
J Drug Target 12:309-404. 2004
Research Grants
- MOLECULAR BASES OF CELL ADHESIONRudolph Juliano; Fiscal Year: 1993....
- Enhanced Delivery of Protein Biosensors: a Combinatorial Library StrategyRudolph Juliano; Fiscal Year: 2007..We anticipate that this approach will lead to a cohort of novel CPPs that will have an important impact on the entire field of intracellular delivery of proteins, especially biosensors. ..
- Conference on Signaling Via Cell-Cell InteractionsRudolph Juliano; Fiscal Year: 2003..The proposed program will present a unique training opportunity for students and post-doctoral fellows, since it will provide a unifying thematic structure to converging, but still disparate, areas of research. ..
- MOLECULAR BASES OF CELL ADHESIONRudolph Juliano; Fiscal Year: 2003....
- TARGETING CANCER CELL DNA WITH COMBINATORIAL LIGANDSRudolph Juliano; Fiscal Year: 2005..They will also provide new molecular tools that could prove to be valuable adjuncts for cancer chemotherapy. ..
- Major Challenges in Clinical Medicine: An Overview for *Rudolph Juliano; Fiscal Year: 2006..As part of this component the trainee, with the mentor's guidance, will prepare the Abstract and Specific Aims of an NIH-type grant proposal dealing with a translational research topic. ..
- Carolina Center of Cancer Nanotechnology ExcellenceRudolph Juliano; Fiscal Year: 2007....
- TARGETING CANCER CELL DNA WITH COMBINATORIAL LIGANDSRudolph Juliano; Fiscal Year: 2000..We also believe that they will create opportunities for the development of novel approaches to cancer therapy. ..
- Enhanced Delivery of Protein Biosensors: a Combinatorial Library StrategyRudolph Juliano; Fiscal Year: 2009..We anticipate that this approach will lead to a cohort of novel CPPs that will have an important impact on the entire field of intracellular delivery of proteins, especially biosensors. ..
